The Americas Committee for Treatment & Research in Multiple Sclerosis (ACTRIMS®) provides leadership in the field of MS and other demyelinating diseases through its three core activities; meetings, education and community. ACTRIMS® offers and supports activities that provide exchange of information, debate current issues and discuss advances related to basic and clinical issues in MS research. ACTRIMS® also seeks to encourage young clinicians and researchers to continue their careers in MS and other
demyelinating diseases.
ACTRIMS® hosts an annual meeting titled ACTRIMS Forum, as well as co-hosts a joint meeting in conjunction with its European counterpart, ECTRIMS every three years.